Home/Pipeline/Transcend Therapeutics Portfolio

Transcend Therapeutics Portfolio

Neuropsychiatry

Acquisition announcedActive

Key Facts

Indication
Neuropsychiatry
Phase
Acquisition announced
Status
Active
Company

About Otsuka

Otsuka America Pharmaceutical, Inc. is the U.S. pharmaceutical arm of Japan's Otsuka Holdings, operating as a commercial-stage biopharmaceutical company. It has a long-standing legacy in neuroscience with marketed products and is actively expanding its pipeline in nephrology, immunology, and CNS disorders through internal R&D and strategic acquisitions like Transcend Therapeutics. The company is led by a seasoned executive team and leverages the global resources of its parent organization to address significant unmet medical needs.

View full company profile